Literature DB >> 32514199

Cost-effectiveness of emergency care interventions in low and middle-income countries: a systematic review.

Kalin Werner1, Nicholas Risko2, Taylor Burkholder3, Kenneth Munge4, Lee Wallis1, Teri Reynolds5.   

Abstract

OBJECTIVE: To systematically review and appraise the quality of cost-effectiveness analyses of emergency care interventions in low- and middle-income countries.
METHODS: Following the PRISMA guidelines, we systematically searched PubMed®, Scopus, EMBASE®, Cochrane Library and Web of Science for studies published before May 2019. Inclusion criteria were: (i) an original cost-effectiveness analysis of emergency care intervention or intervention package, and (ii) the analysis occurred in a low- and middle-income setting. To identify additional primary studies, we hand searched the reference lists of included studies. We used the Consolidated Health Economic Evaluation Reporting Standards guideline to appraise the quality of included studies.
RESULTS: Of the 1674 articles we identified, 35 articles met the inclusion criteria. We identified an additional four studies from the reference lists. We excluded many studies for being deemed costing assessments without an effectiveness analysis. Most included studies were single-intervention analyses. Emergency care interventions evaluated by included studies covered prehospital services, provider training, treatment interventions, emergency diagnostic tools and facilities and packages of care. The reporting quality of the studies varied.
CONCLUSION: We found large gaps in the evidence surrounding the cost-effectiveness of emergency care interventions in low- and middle-income settings. Given the breadth of interventions currently in practice, many interventions remain unassessed, suggesting the need for future research to aid resource allocation decisions. In particular, packages of multiple interventions and system-level changes represent a priority area for future research. (c) 2020 The authors; licensee World Health Organization.

Entities:  

Mesh:

Year:  2020        PMID: 32514199      PMCID: PMC7265944          DOI: 10.2471/BLT.19.241158

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


Introduction

Emergency care is a health systems and service delivery innovation that facilitates early recognition and life-saving interventions for time sensitive acute injuries and illnesses, where a delay of hours may result in avoidable death or disability, or make treatments less effective., Frontline providers deliver these interventions across the emergency care system, from scene care to transport to facilities. Conditions addressed by emergency care include trauma, infections, noncommunicable disease and complications of pregnancy. These conditions accounted for nine of the 10 leading causes of death in low-income countries in 2017. For people aged 5–29 years, the most common cause of death is road traffic crashes, causing over 28 million deaths a year, of which most occurring in low- and middle-income countries. Researchers have estimated that over half of deaths in low- and middle-income countries, and up to 2.5 billion disability-adjusted life-years (DALYs) annually, could be addressed through the implementation of effective emergency care. These figures are expected to grow due to factors such as increased use of motor vehicles, increased urbanization and lifestyle changes leading to increases in coronary heart disease. Traumatic injury alone is anticipated to represent a fifth of all ill-health worldwide by 2020., Early recognition of acute conditions by the health-care system, and improved access to care, could address much of the ill-health burden and save millions of lives. These facts have been acknowledged by the World Health Assembly Resolution Emergency care systems for universal health coverage: ensuring timely care for the acutely ill and injured. Emergencies occur regardless of whether a health system is prepared to address them. An organized emergency care system can theoretically leverage economies of scope and scale by employing simple low-cost interventions that will save millions of lives. However, little is known about the cost–effectiveness of emergency care interventions in low- and middle-income countries (LMIC), where such interventions may have the greatest impact. Cost–effectiveness data is essential to inform the resource allocation decisions of policy-makers and regulators. Such data encourages the prioritization of systems and interventions most likely to provide a health and economic benefit. A survey of policy-makers in Brazil, Cuba, Nepal, Norway, and Uganda demonstrated a majority preference for efficiency arguments, such as cost–effectiveness, in formalizing the health priority setting process. Here, we present a systematic review on the cost–effectiveness of emergency care interventions in low- and middle- income countries. Our aim was to characterize the existing knowledge regarding the costs and benefits of delivering emergency care in these settings, to examine the quality of cost–effectiveness analyses and to provide guidance for future research efforts.

Methods

Search strategy

We systematically reviewed the literature on emergency care interventions in low- and middle-income countries. We searched for peer-reviewed articles published before May 2019, in PubMed®, Scopus, Embase®, Cochrane Library and Web of Science. To capture the heterogeneity of emergency care interventions, we included components of both pre-hospital and facility-based emergency care system. An example of the search terms used is shown in Box 1 and the full search strategy is available in the data repository. We applied no language restrictions. To limit search results to our context of interest we applied the Cochrane LMIC filter. The study was designed in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines and was prospectively registered with PROSPERO (CRD42018080145). Example of search terms for PubMed: (“Cost-Benefit Analysis”[mh] OR “cost benefit” OR “cost-benefit” OR “cost effective” OR “cost-effective” OR “cost effectiveness” OR “cost–effectiveness” OR “cost utility” OR “cost-utility”) AND (“Emergency Service, Hospital”[mh] OR “Emergency Medicine”[mh] OR “Emergency medicine”[TW] OR “Emergency services”[TW] OR “Emergency department”[TW] OR “Emergency service”[TW] OR “Emergency departments”[TW] OR “Emergency room”[TW] OR “Emergency rooms”[TW] OR “Emergency ward”[TW] OR “Emergency Unit”[TW] OR “Trauma Centers”[mh] OR “Trauma Center”[TW] OR “Trauma Centers”[TW] OR “emergency health service”[TW] OR “emergency health services”[TW] OR “emergency medical services”[TW] OR “emergency medical service”[TW] OR “accident and emergency”[TW] OR “accident & emergency”[TW] OR “a&e”[TW] OR “A & E”[TW] OR “prehospital”[TW] OR “ambulance”[TW]) AND Cochrane Filter Note: We used the LMIC Cochrane filter.

Selection of studies

We uploaded all identified studies into the software Covidence (Covidence, Melbourne, Australia) for review. Studies were considered for inclusion if they: (i) described a system-wide or individual emergency care intervention; (ii) were implemented in a low- and middle- income country (according to 2018 World Bank classification) or analysed costing data from a low- and middle- income country; and (iii) undertook a full economic evaluation (either a cost–effectiveness analysis, cost-utility analysis or cost-benefit analysis). We defined emergency care interventions as interventions that provide or facilitate the early care of acutely injured and ill patients, whether outside or inside a health-care facility. This definition included early critical care or surgical interventions that commonly take place in an emergency department. Two reviewers independently assessed titles and abstracts for inclusion of the articles for the full text review. The reviewers only selected studies for full text review if both agreed that the studies met the inclusion criteria. Studies then underwent full text reviews for eligibility by two independent reviewers. Disagreements were resolved by consensus within the study team. To identify additional primary studies, we hand searched the reference lists of included studies.

Quality assessment

Two reviewers appraised the included studies using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. To better understand the quality of data, we did a comprehensive scoring of studies, by giving one point for each fulfilled item on the checklist, however, we did not exclude any studies based on quality.

Data abstraction

The following information was extracted from included studies: country; year of publication; intervention; comparator; time horizon; discount rate, study perspective, health outcome, sensitivity analyses and findings. We converted cost results or the cost part of the incremental cost–effectiveness ratios to 2019 Untied States dollars (US$) for comparability. Due to the lack of consensus surrounding the use of cost–effectiveness thresholds,, we did not apply a global benchmark to each study’s results, but left the results to be interpreted within the specific study context.

Results

Overview of included studies

By searching the five databases, we identified 1674 unique articles. After screening titles and abstracts for eligibility, 137 articles remained for full text screening. Of these studies, 35 studies met all the inclusion criteria and were eligible for data abstraction. Additionally, we included four eligible studies identified through hand searching of reference lists (Table 1).–
Table 1

Findings of included studies in the systematic review on cost–effectiveness analyses for emergency care

Author, yearCountryStudy type and perspectiveSample sizeInterventionFindingsaCHEERS scoreb
Prehospital services
Hauswald et al., 199727MalaysiaModelling, NANAEstablishing an emergency medical services system responding to out-of-hospital cardiac arrestU$ 568 642 per life saved6
Somigliana et al., 201123UgandaObservational, district health provider92Implementing an ambulance service for reproductive health in a remote settingUS$ 17.97 per year of life saved13
Jaldell et al., 201419ThailandModelling, NANADecreasing emergency medical services response time by 1 minute, nationallySavings of US$ 425 million to US$ 850 million for the national health system12
de Ramirez et al., 201416UgandaObservational, NA207Establishing an emergency medical services response systemUS$ 97.10 per life saved9
Accorsi et al., 201715EthiopiaObservational, district health provider111Establishing ambulance service dedicated to emergency obstetric careUS$ 27 per life year saved17
Provider training
Arreola-Risa et al., 200038MexicoObservational, NA866Course on prehospital trauma life support and increased number of ambulance dispatch centresIncreased use of prehospital interventions, decreased percentage of patients who died in transport, and costed 15.9% (US$ 77 600/ US$ 488 000) of ambulance budget9
Arreola-Risa et al., 200437MexicoObservational, NA866Basic trauma training for ambulance personnel and to improve ambulance response timeFor a cost of US$ 123 555, prehospital mortality declined after medic arrival on scene from 8.2% (29/353) to 4.7% (23/491)12
Jayaraman et al., 200931UgandaCross-sectional, NA307Trauma course for lay first-respondersUS$ 30–89 per life year saved14
Carlson et al., 201239HaitiModelling, NANA2-year orthopaedic trauma residencyAverage of US$ 149 (SD: 39) per DALY averted for the health system17
Clark et al., 201225Sierra LeoneObservational cohort study, NA3584Emergency triage assessment and treatment training, triage implementation, and designation of space for emergency departmentUS$ 165 per paediatric death averted14
Willcox et al., 201733GhanaCohort study, NA105 850Training nurses and midwives in basic emergency obstetric and newborn careUS$ 57.34 per DALY averted for the health provider22
Treatment interventions
Jha et al., 199824GuineaModelling, health-care systemNAVarious treatment interventions provided for severe conditions at first level referral hospitalsCosts for per life year saved: pneumonia in children US$ 54; malnutrition US$ 73; injury US$ 483; diarrhoea US$ 129; and malaria US$ 15116
Patel et al., 200351IndiaRCT, patient and government health-care provider200Treating acute diarrhoea in children with zinc and copperUS$ 23 per treatment of episode18
Gregorio et al., 200753PhilippinesRCT, societal117Zinc supplement for children with acute diarrhoeaSavings for society of US$ 3.33 for each day that diarrhoea is averted fewer than 4 days from consult, with a spending of US$ 0.04 for each case of diarrhoea lasting fewer than 4 days from consult14
Ozelo et al., 200752BrazilObservational, Brazilian national health service103rFVIIa as first-line treatment for mild-to-moderate bleeding in patients with hemophilia compared to activated prothrombin complex concentrateWhen used as first-line treatment in patients with hemophilia, rFVIIa was more effective and less expensive per bleeding episode (100%; 36/36 patients; US$ 7 490) than activated prothrombin complex concentrate (56.7%; 38/67 patients; US$ 13 500)15
Duke et al., 200836Papua New GuineaCohort. NA 11 291Improved oxygen system, including pulse oximeters, supplies and protocols, for children with pneumoniaDecreased risk of death by 35% (from 4.97% to 3.22%), costing US$ 66 per DALY averted or US$ 2 205 per life saved15
Turhan et al., 200932TurkeyCohort, NA290Non-operative management of acute appendicitisUS$ 580–731 per patient treated6
Guerriero et al., 201145India, United Kingdom and United Republic of TanzaniaModelling, health serviceNATranexamic acid injection for bleeding trauma patients within 3 hours of injuryIncremental cost per life year gained was US $79 in India, US$ 76 in United Kingdom and US$ 57 in United Republic of Tanzania22
Chen et al., 201448MalawiNon-RCT, health-care system87Bubble continuous positive airway pressure for neonates in respiratory distressUS$ 55 per life year gained for the health-care system18
Champunot et al., 201446ThailandObservational, health-care provider1048Resuscitation in the emergency department and early intensive care unit admission for severe sepsis or septic shockUS$ 1 671 per life saved17
Assuncao et al., 201435BrazilCohort, NA414Standardized protocol for severe sepsisMortality reduced from 57% (182/322) to 38% (35/92). Reduction of intensive care unit costs from U$ 162 005 (SD: 237 221) to US$ 100 181 (SD: 149 388) and an average gain of 3.2 life-years after discharge14
Wang et al., 201442ChinaModelling, societalNAAspirin, statin, β-blocker, ACE inhibitor, ARB and heparin for non-ST-elevation myocardial infarction. For ST-elevation myocardial infarction percutaneous coronary intervention in tertiary hospitals and streptokinase in secondary hospitalNon-ST-elevation myocardial infarction: US$ 3 291 per QALY saved;ST-elevation myocardial infarction: US$ 13 054 per QALY saved22
Castro Jaramillo et al., 201643ColombiaModelling, health system NAFactor VIII treatment following a significant bleeding in patients with hemophilia AUS$ 60 557 per QALY gained23
Irazuzta et al., 201630ParaguayRandomized open-label study, NA38High dose prolonged magnesium sulfate infusion for severe asthmaCost per treatment US$ 761–1014. Treatment expedites discharge, which results in cost saving due to reduced duration of hospital stay8
Pinto et al., 201622BrazilMeta-analysis and modelling, NANATranexamic acid injection in trauma patientsUS$ 17 per life year saved12
Dayananda et al., 201726South AfricaCohort, NA501Selective non-operative management of penetrating abdominal traumaCompared to mandatory laparotomy, intervention is effective (all patients treated survived with no complications) and saves US$ 197 263 for the health-care provider11
Kortz et al., 201740MalawiModelling, government hospitalNABubble continuous positive airway pressure for paediatric severe pneumoniaUS$ 14 per DALY averted22
Dwommoh et al., 201850South AfricaRCT, patient and provider332Motivational interviewing and problem-solving therapy interventions to reduce substance use disorder and depressive symptomsUS$ 4–20 per patient yielded improvement in mental health measured by a per unit reduction of scores on the Alcohol, Smoking and Substance Use Involvement Screening Test and the Centre for Epidemiological Studies Depression Scale18
Yang et al., 201834ChinaObservational, NA1189Standardized treatment for acute strokeStandardized treatment for acute stroke dominated usual care. Saving of US$ 3.34–18.30 per 1% increment of the effective management rate 9
Tigabu et al., 201947Islamic Republic of Iran Modelling, health-care payerNATreatment of severe sepsis and septic shockUS$ 11 344–11 898 per life year gained15
Emergency diagnostic tools
Schulman-Marcus et al., 201044IndiaModelling, societalNAElectrocardiography for patients with acute chest pain presenting to a general physicianUS$ 16 per QALY gained24
Bogavac-Stanojević et al., 201349SerbiaObservational, third-party payer192D-dimer testing for deep vein thrombosis Using diagnostic VIDAS® D-dimer exclusion II assay versus Hemosil D-dimer HS assay costs US$ 0.30 versus US$ 1.58 per one additional deep vein thrombosis positive patient (without pre-test probability score), and US$ 0.72 vs US$ 1.19 per one deep vein thrombosis positive patient (with pre-test probability score) selected for compression ultrasonography18
Facilities and packages of care
Horton & Claquin, 198328BangladeshModelling, NA11 509Comparing three services for the treatment of diarrhoea, including large hospital centre, an ambulance system and a stand-alone diarrhoeal treatment centreCost per death averted: large centre US$ 4 032 (SD: 1 116) if patient came by ambulance compared to US$ 589 at diarrhoeal treatment centre without ambulance11
McCord & Chowdhury, 200321BangladeshObservational, NA555Acute care facility providing a package of emergency services, including early access to surgical and obstetric careUS$ 18 per DALY for the hospital site13
Hu et al., 200729MexicoModelling, NANAIncreasing access to comprehensive emergency obstetric care and increasing coverage levels in the WHO Mother Baby Package standard of careAccess: US$ 380 per DALY averted; coverage: US$ 697 per life year saved and US$ 494 per DALY averted20
Gosselin et al., 200818CambodiaObservational, NA957A district trauma hospital serving as a surgical care centre for injured patientsUS$ 98 per DALY averted for the health centre because of surgery care for trauma14
Gosselin et al., 201017Haiti and NigeriaObservational, NA6746Emergency surgical and trauma care facilities supported by Médecins Sans FrontièresUS$ 265 in Haiti and US $204 in Nigeria per DALY averted for the health centre because of the existence of surgical trauma programmes 12
Barasa et al., 201241KenyaCluster RCT, health-care provider 11 314Full implementation of emergency triage assessment and treatment guidelinesUS$ 0.94 per child admitted achieving one percentage point improvement in quality measure US$ 47.41–474.44 per DALY averted for national scale up23
Kotagal et al., 201420122 low- and middle-income countries and 44 high-income countriesModelling, NA6640 millionReducing injury mortality rates in low and middle-income countries to high-income rates2 117 500 lives could be saved per year with economic benefit ranges from US$ 245 billion–261 billion (using a human capital approach) and US$758 billion–786 billion per year (using a statistical life approach)17

ACE: angiotensin-converting-enzyme; ARB: angiotensin-II receptor blocker; β blocker: Beta blocker; CHEERS: Consolidated Health Economic Evaluation Reporting Standards; DALY: disability-adjusted life-years; HS assay: High Sensitive assay; NA: not applicable; rFVIIa: recombinant activated factor VII; RCT: randomized controlled trial; SD: standard deviation; QALY: quality adjusted life year; US$: United States dollars.

a We adjusted findings to 2019 US$.

b Maximum score is 24. Details about the scoring is available in the data repository.

ACE: angiotensin-converting-enzyme; ARB: angiotensin-II receptor blocker; β blocker: Beta blocker; CHEERS: Consolidated Health Economic Evaluation Reporting Standards; DALY: disability-adjusted life-years; HS assay: High Sensitive assay; NA: not applicable; rFVIIa: recombinant activated factor VII; RCT: randomized controlled trial; SD: standard deviation; QALY: quality adjusted life year; US$: United States dollars. a We adjusted findings to 2019 US$. b Maximum score is 24. Details about the scoring is available in the data repository. The reasons for exclusion during the full text screening were: not done in a low- and middle- income country (nine studies): did not contain cost–effectiveness analyses (44 studies); did not address emergency care interventions (17 studies); were not a research article (26 studies); or were not available in full text either online or by request (six studies; Fig. 1).
Fig. 1

Flowchart on the selection of studies for the systematic review on cost–effectiveness analyses for emergency care interventions

Flowchart on the selection of studies for the systematic review on cost–effectiveness analyses for emergency care interventions Table 2 shows the overall grading of quality for each article section, the detailed CHEERS scoring of each included article is available in the data repository.
Table 2

Quality score of included studies on cost–effectiveness analyses for emergency care

Section, itemAdequately reported in study, no. (%)Overall quality
Title31 (79)Medium
Abstract37 (95)High
Introduction
Background and objectives38 (97)High
Methods
Target population and subgroups37 (95)High
Setting and Location36 (92)High
Study perspective17 (44)Low
Comparators28 (72)Medium
Time horizon12 (31)Low
Discount rate17 (44)Low
Choice of health outcomes29 (74)Medium
Effectiveness31 (79)Medium
Preference valuation14 (36)Low
Costs33 (85)High
Currency, price date, conversion30 (77)Medium
Choice of model16 (41)Low
Assumptions16 (41)Low
Analytical methods14 (36)Low
Results
Study parameters17 (44)Low
Incremental costs and outcomes27 (69)Medium
Uncertainty17 (44)Low
Heterogeneity5 (13)Low
Discussion
Study findings, limitations and generalizability37 (95)High
Other
Source of funding23 (59)Medium
Conflict of interest21 (54)Medium

Notes: We used the Consolidated Health Economic Evaluation Reporting Standards checklist. We deemed the overall quality of each item as low if the percentage was below 50%, medium if the percentage was between 50% and 80%, and high if the percentage was above 80%.

Notes: We used the Consolidated Health Economic Evaluation Reporting Standards checklist. We deemed the overall quality of each item as low if the percentage was below 50%, medium if the percentage was between 50% and 80%, and high if the percentage was above 80%. Only three studies considered a broader societal perspective,42.42, while 14 studies considered a health-care perspective.,,,,,,– The remaining 22 studies did not clearly indicate the perspective used in the study.–,– Ten studies did not clearly describe the comparator being used.– Standardized metrics for health outcomes that allow for cross-intervention comparison were used in 26 studies. Most studies (13) used the life years saved or gained as health outcome,,,,–,,,,,– nine studies reported DALYs,,,,,,– and three studies reported quality adjusted life years (QALYs).– The other 13 studies reported findings in unique metrics that prohibit comparison to other disease programmes.,,,,,,,,– Only 12 studies clearly stated the structural assumptions underpinning their decision-analytic model,,,,–, and only 15 studies adequately described the analytical methods used to support their evaluations.,,,,,,–,,,, Although all studies analysed both costs and health outcomes, 12 studies failed to report an incremental cost–effectiveness ratio.,,,,,,,,,,, Of the 17 studies reporting uncertainty analyses, 10 were deterministic,,,–,,, and seven used probabilistic sensitivity analyses.,,,,,, The remaining 22 studies did not adequately report the use of sensitivity analyses to assess uncertainty of either parameters or the model.–,–,,,–,,, Only five studies reported on analysis of heterogeneity, making this item the most poorly reported checklist item.,,,,

Description of included studies

Included studies fell within five broad categories: prehospital services; training; treatment interventions; diagnostic tools; and facilities and/or packages of care. These categories are not mutually exclusive, but rather reflect the primary nature of the intervention studied. Table 1 shows a summary of all included articles, interventions assessed and main findings.

Prehospital services

Five studies investigated the impact of either introducing a professional ambulance service or improving ambulance response times. Two studies looked specifically at the establishment of ambulance services for obstetric care,, one at establishing a general emergency medical services system, one for cardiac arrest care, and one modelled the impacts of a decrease in response time. The cost–effectiveness of establishing an ambulance system ranged from US$ 18 in Uganda to US$ 568 642 in Malaysia per life year saved., In Thailand, reducing the response time would decrease the yearly national health-care expenditure by US$ 425 million to US$ 850 million for each minute saved. The wide range of results in this category is attributable to significant heterogeneity in the costs, exact interventions provided and impact data used for the analysis.

Provider training

Six studies assessed the impact of training interventions,,,,– three of which studied prehospital training.,, These prospective studies assessed training in a variety of cadres, from lay first-responders to orthopaedic specialists. Strengthening the human resource capacity to provide trauma care ranged from US$ 30 per life year saved for lay first-responders to US$ 188 per life year saved for orthopaedic trauma residency.

Treatment interventions

Nineteen studies compared different treatments or patient care pathways. Four studies assessed the treatment of acute bleeding, including two for tranexamic acid injection in trauma patients, and two studies for recombinant activated factor VII injection in patients with hemophilia., Cost–effectiveness for tranexamic acid was between US$ 17 and US$ 76 per life year saved. For recombinant activated factor VII injection, the total direct cost was US$ 7490 per bleeding episode and US$ 60 557 per QALY gained. Other studies assessed operative versus non-operative management of appendicitis, treatment interventions for severe conditions at first level referral hospitals, treatment of abdominal penetrating trauma, severe asthma, acute myocardial infarction, paediatric respiratory distress,,, acute paediatric diarrhoea,, severe sepsis and septic shock,,, protocolized treatment for acute stroke and substance abuse interventions.

Emergency diagnostic tools

Two studies assessed emergency care diagnostic tools., For example, a modelling study showed that using an electrocardiogram for patients with chest pain in India costs US$ 16 per QALY gained.

Facilities and packages of care

Four studies assessed the cost–effectiveness of the provision of facility-based emergency care. Three studies focused on the provision of surgical care,, while one evaluated a stand-alone diarrhoea treatment centre. The cost–effectiveness of facilities providing surgical care varied from US$ 18 to 265 per DALY averted,,, and US$ 4032 per death averted for a diarrhoeal treatment centre. Although most studies analysed actual interventions, three studies used modelling to predict the impact of increased coverage and improved quality of service.,, Authors of one paper estimated that the economic benefit would be within the range of U$ 758 billion–786 billion per year globally if the mortality rates in low- and middle-income countries were reduced to the rates in high-income countries. Other findings show that implementing guidelines and improving the standard of care yielded incremental cost–effectiveness ratios between US$ 47 and US$ 474 per DALY.

Discussion

We sought to systematically collect and critically appraise the existing literature on the cost–effectiveness of emergency care interventions in low- and middle- income countries. Cost–effectiveness analyses are important for assessing the value for money of emergency care interventions and to allow for prioritization and optimal resource allocation. Formulating a general conclusion about the wider implication of the findings on the cost–effectiveness of emergency care is problematic, because of the heterogeneity of methods, settings, and presentation of results of the identified studies. For example, few studies used health outcomes that are widely comparable against other disease programmes, such as QALYs or DALYs. This lack, coupled with inconsistent reporting of incremental cost–effectiveness ratios, makes the comparison between the findings of these assessments and other programmes difficult for decision-makers with constrained budgets. Furthermore, some studies fell short of using a contextually-oriented study design and, where possible, empirically derived local inputs. For example, one study used parameters from a high-income setting to estimate cost–effectiveness in a middle-income country, generating results that are difficult to interpret. Overall, we noted that most of the studies were methodologically weak by the quality criteria we applied, failing to provide detailed descriptions of the assumptions taken. Assumptions used to calculate costs and outcomes can greatly influence the final cost estimate and reporting these details can help decision-makers understand to what level these findings apply to their setting and what level of uncertainty was taken in the review. Furthermore, not reporting the comparator used will hinder readers to understand the context of the results. Only two-thirds of the studies provided an incremental cost–effectiveness ratio, which aid decision-makers by allowing for comparability across interventions and the application of a cost–effectiveness threshold. Even in the setting of standardized methods and results reporting, there continues to be a lack of expert consensus surrounding the interpretation of cost–effectiveness data outside the original study context that produced it. While the application of gross domestic product-based global thresholds remains a common approach, consideration of willingness-to-pay for health benefits, identification of benchmark interventions, assessment of budgetary-impact, and incorporation of league tables allow for improved contextualization of results and utility for decision-makers.,, When comparing the results of our included studied with readily available collated data from other public health interventions, we recommend readers go to the primary literature and ensure context and methodologic comparability. Another notable finding from our review is that the research focused on single-intervention analyses rather than intervention packages or system changes. An organized emergency care system has the capacity to treat a variety of conditions with a common set of resources, thus gaining efficiencies in per-unit costs by applying economies of scope. Additional positive effects across the health system, such as reducing downstream health-care costs, contributing to public health surveillance and preparedness for disasters, can be also achieved by the organization and alignment of emergency care services. More research is needed on the cost–effectiveness of system changes, process improvement and intervention packages. Furthermore, an exclusive health-care perspective was used in most the studies, which may undervalue the broad social impacts and economic burden of lost workforce productivity that can be mitigated with emergency care. This narrow scope of analysis may obscure the broader productivity and economic gains that emergency care interventions provide. Over 80 studies excluded in the review were costing-only assessments (i.e. no measure of efficacy or benefit was assessed). These studies were often descriptive costing studies of a disease entity used to justify spending on preventive measures. For example, the authors of a cost analysis of interpersonal violence in South Africa concluded that the costs of in-hospital care of violence victims warrants investment in primary prevention of these injuries. Costing-only studies were also employed for budget-impact analysis between two choices, including (i) contrasting expenditures between two health-care settings for a single disease entity and (ii) contrasting expenditures between two patient populations. One study reported an incremental cost–effectiveness ratio calculated by using the reduction in treatment time as a primary outcome rather than a health outcome and therefore was not extracted for final review. When evaluating the research gap, we noticed a sizable discrepancy between the breadth of emergency care interventions in low- and middle- income countries and the amount of published research from these settings. Of the articles we assessed, only 24 out of 137 low- and middle- income countries globally are represented in our findings, indicating a significant gap in research. Finally, a limitation of our study surrounds the difficulty of labelling emergency care interventions for searchability. Although, we attempted to capture all literature related to emergency care, there may be relevant articles, which were not caught in our search criteria. Unless authors clearly tagged the intervention with terms related to “emergency care,” their study may not have been captured by our search. For this reason, we hand-searched references of included articles, yielding several additional studies. Our systematic review demonstrates a relative sparsity of evidence regarding the cost–effectiveness of emergency care interventions in low-and middle-income countries. Given the breadth of available interventions, numerous potentially low- and high-cost interventions and their impacts remain unevaluated. Our review highlights areas for improvement in the quality of methods and study-design that would facilitate the use of future studies in the decision-making process with regards to the allocation of resources. Overall, the included studies allow us to begin to characterize the literature and establish a research agenda in this area. A primary focus of the future research is the development of cost–effectiveness analyses that evaluate emergency care as a system of integrated care delivery, considering economies of scope and the broader impact of organizing, and aligning health-care provision.
  50 in total

1.  Cost-effectiveness of a district trauma hospital in Battambang, Cambodia.

Authors:  Richard A Gosselin; Merja Heitto
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

2.  Cost effectiveness analysis of an initial ICU admission as compared to a delayed ICU admission in patients with severe sepsis or in septic shock.

Authors:  Ratapum Champunot; Thammasak Thawitsri; Nataya Kamsawang; Visanu Sirichote; Cherdchai Nopmaneejumruslers
Journal:  J Med Assoc Thai       Date:  2014-01

3.  Ambulance service within a comprehensive intervention for reproductive health in remote settings: a cost-effective intervention.

Authors:  Edgardo Somigliana; Alice Sabino; Richard Nkurunziza; Emmy Okello; Gianluca Quaglio; Peter Lochoro; Giovanni Putoto; Fabio Manenti
Journal:  Trop Med Int Health       Date:  2011-06-21       Impact factor: 2.622

4.  The cost-effectiveness of forty health interventions in Guinea.

Authors:  P Jha; O Bangoura; K Ranson
Journal:  Health Policy Plan       Date:  1998-09       Impact factor: 3.344

5.  Comparison of operative and non operative management of acute appendicitis.

Authors:  Ahmet Nuray Turhan; Selin Kapan; Ersen Kütükçü; Hakan Yiğitbaş; Sinan Hatipoğlu; Erşan Aygün
Journal:  Ulus Travma Acil Cerrahi Derg       Date:  2009-09

6.  Zinc supplementation reduced cost and duration of acute diarrhea in children.

Authors:  Germana V Gregorio; Leonila F Dans; Cynthia P Cordero; Carlo A Panelo
Journal:  J Clin Epidemiol       Date:  2006-12-11       Impact factor: 6.437

7.  Economic evaluation of zinc and copper use in treating acute diarrhea in children: A randomized controlled trial.

Authors:  Archana B Patel; Leena A Dhande; Manwar S Rawat
Journal:  Cost Eff Resour Alloc       Date:  2003-08-29

8.  Cost-effectiveness analysis of a low-cost bubble CPAP device in providing ventilatory support for neonates in Malawi - a preliminary report.

Authors:  Ariel Chen; Ashish A Deshmukh; Rebecca Richards-Kortum; Elizabeth Molyneux; Kondwani Kawaza; Scott B Cantor
Journal:  BMC Pediatr       Date:  2014-11-25       Impact factor: 2.125

Review 9.  USE OF TRANEXAMIC ACID IN TRAUMA PATIENTS: AN ANALYSIS OF COST-EFFECTIVENESS FOR USE IN BRAZIL.

Authors:  Marcelo A Pinto; Jair G da Silva; Aljamir D Chedid; Marcio F Chedid
Journal:  Arq Bras Cir Dig       Date:  2016 Nov-Dec

10.  The cost of time: A randomised, controlled trial to assess the economic impact of upfront, point-of-care blood tests in the Emergency Centre.

Authors:  Lara Nicole Goldstein; Mike Wells; Craig Vincent-Lambert
Journal:  Afr J Emerg Med       Date:  2019-03-01
View more
  4 in total

1.  Economic Evaluations of Child Nutrition Interventions in Low- and Middle-Income Countries: Systematic Review and Quality Appraisal.

Authors:  Yeji Baek; Zanfina Ademi; Susan Paudel; Jane Fisher; Thach Tran; Lorena Romero; Alice Owen
Journal:  Adv Nutr       Date:  2022-02-01       Impact factor: 11.567

2.  Barriers to Trauma Care in South and Central America: a systematic review.

Authors:  Florence Kinder; Sarah Mehmood; Harry Hodgson; Peter Giannoudis; Anthony Howard
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-08-14

3.  Clinical and Economic Burden of Stroke Among Young, Midlife, and Older Adults in the United States, 2002-2017.

Authors:  Safi U Khan; Muhammad Zia Khan; Muhammad U Khan; Muhammad Shahzeb Khan; Mamas A Mamas; Muhammad Rashid; Ron Blankstein; Salim S Virani; Michelle C Johansen; Michael D Shapiro; Michael J Blaha; Miguel Cainzos-Achirica; Farhaan S Vahidy; Khurram Nasir
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-04-08

4.  The costs of delivering emergency care at regional referral hospitals in Uganda: a micro-costing study.

Authors:  Kalin Werner; Tracy Kuo Lin; Nicholas Risko; Martha Osiro; Joseph Kalanzi; Lee Wallis
Journal:  BMC Health Serv Res       Date:  2021-03-16       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.